Inventor
Celia Dominguez
Inventor
Los Angeles, CA, US
Overview
Patents· 86 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds37%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61KPreparations for medical, dental or toiletry purposes17%
C07CAcyclic or carbocyclic compounds5%
Y02ATechnologies for adaptation to climate change4%
C07BGeneral methods of organic chemistry2%
C07HSugars1%
A61BDiagnosis1%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
C07KPeptides1%
PatentTitleYear
11,104,691Probes for imaging huntingtin protein202111,071,793Probes for imaging huntingtin protein202111,059,836Probes for imaging huntingtin protein202110,765,764Probes for imaging huntingtin protein202010,501,433Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof201910,479,802Probes for imaging huntingtin protein201910,457,675Histone deacetylase inhibitors and compositions and methods of use thereof201910,442,782Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof201910,428,054Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof201910,258,621Methods and compositions for treating HIV-related disorders201910,137,211Probes for imaging Huntingtin protein201810,105,363Histone deacetylase inhibitors and compositions and methods of use thereof201810,106,535Histone deacetylase inhibitors and compositions and methods of use thereof201810,065,948Histone deacetylase inhibitors and compositions and methods of use thereof201810,053,434Histone deacetylase inhibitors and compositions and methods of use thereof201810,047,073Histone deacetylase inhibitors and compositions and methods of use thereof20189,981,918Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof20189,938,252Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof20189,884,853'Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof'20189,855,267'Histone deacetylase inhibitors and compositions and methods of use thereof'20189,822,058'Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof'20179,783,488'Histone deacetylase inhibitors and compositions and methods of use thereof'20179,765,054'Histone deacetylase inhibitors and compositions and methods of use thereof'20179,649,310'Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof'20179,617,259'Histone deacetylase inhibitors and compositions and methods of use thereof'20179,562,021'Histone deacetylase inhibitors and compositions and methods of use thereof'20179,505,736'Histone deacetylase inhibitors and compositions and methods of use thereof'20169,428,464'Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof'20169,260,422'Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof'20169,145,373'Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof'20159,096,565'Inhibitors of histone deacetylase'20158,946,197'Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof'20158,889,716'Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof'20148,883,785'Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof'20148,691,824'Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof'20148,685,983'Method of treating cancer with substituted amide derivatives'20148,642,624'Substituted alkylamine derivatives and methods of use'20148,536,186'Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof'20138,088,794'Substituted amide derivatives and methods of use'20128,084,479'Thiazole compounds and methods of use'20118,026,241'Vanilloid receptor ligands and their use in treatments'20118,017,601'Bis-aryl kinase inhibitors and method'20117,919,504'Thiadiazole modulators of PKB'20117,897,619'Heterocyclic modulators of PKB'20117,858,623'Substituted amide derivatives and methods of use'20107,652,009'Substituted heterocycles and methods of use'20107,582,631'Substituted heterocyclic compounds and methods of use'20097,582,761'Vanilloid receptor ligands and their use in treatments'20097,514,564'Substituted amine derivatives and methods of use'20097,514,566'Thiazole compounds and methods of use'20097,354,944'Thiadiazole compounds and methods of use'20087,332,511'Vanilloid receptor ligands and their use in treatments'20087,235,575'Guanidine mimics as factor Xa inhibitors'20077,148,221'Vanilloid receptor ligands and their use in treatments'20067,144,888'Vanilloid receptor ligands and their use in treatments'20067,105,682'Substituted amine derivatives and methods of use'20067,101,868'Substituted arylamine derivatives and methods of use'20067,049,318'Substituted heterocyclic compounds and methods of use'20067,026,326'Substituted heterocyclic compounds and methods of use'20066,995,162'Substituted alkylamine derivatives and methods of use'20066,967,254'Substituted heterocyclic compounds and methods of use'20056,958,356'Guanidine mimics factor Xa inhibitors'20056,921,762'Substituted indolizine-like compounds and methods of use'20056,906,070'Guanidine mimics as factor Xa inhibitors'20056,849,639'Integrin inhibitors and their methods of use'20056,656,930'Aralkyl diazabicycloalkane derivatives for CNS disorders'20036,602,895'Inhibitors of factor Xa with a neutral P1 specificity group'20036,552,042'Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor Xa'20036,521,614'N-(amidinophenyl)cyclourea analogs as factor Xa inhibitors'20036,514,964'Fused cycloheptane and fused azacycloheptane compounds and their methods of use'20036,403,620'Inhibitors of factor Xa with a neutral P1 specificity group'20026,339,099'Guanidine mimics as factor Xa inhibitors'20026,310,064'Aralkyl diazabicycloalkane derivatives for CNS disorders'20016,207,697'Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor Xa'20016,043,257'Amidinoindoles, amidinoazoles, and analogs thereof'20005,998,424'Inhibitors of factor Xa with a neutral P1 specificity group'19995,958,920'Aralkyl diazabicycloalkane derivatives for CNS disorders'19995,925,635'N-(amidinophenyl) cyclourea analogs as factor XA inhibitors'19995,886,191'Amidinoindoles, amidinoazoles, and analogs thereof'19995,856,318'Nitrogen-containing cyclohetero cyclo-heteroaminoaryl derivatives for CNS disorders'19995,731,439'Piperidine containing aminobornic acids'19985,679,679'Aralkyl diazabicycloalkane derivatives for CNS disorders'19975,679,673'Aralkyl bridged diazabicycloalkane derivatives for CNS disorders'19975,656,625'Nitrogen-containing cyclohetero cycloheteroaminoaryl derivatives for CNS disorders'19975,639,739'Imidazole containing aminoboronic acids'19975,346,908'Nitrogen-containing cyclohetero cycloheteroaminoaryl derivatives for CNS disorders'1994Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1994–2003Based in Gaithersburg, MD, US· patent location history
1997–2003Based in Newark, DE, US· patent location history
1999–2003Based in Westlake Village, CA, US· patent location history
2003–2014Patents assigned to AMGEN INC (27)· patent assignee history
2005–2011Based in Thousand Oaks, CA, US· patent location history
2009–2021Based in Los Angeles, CA, US· patent location history
2011–2018Patents assigned to DOMINGUEZ CELIA (15)· patent assignee history
2013–2021Patents assigned to CHDI FOUNDATION INC (35)· patent assignee history
2013–2018Patents assigned to COURTNEY STEPHEN MARTIN (8)· patent assignee history
2013–2018Patents assigned to DE AGUIAR PENA PAULA C (7)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CHDI FOUNDATION INC | 35 | 2013–2021 |
| AMGEN INC | 27 | 2003–2014 |
| DOMINGUEZ CELIAself | 15 | 2011–2018 |
| COURTNEY STEPHEN MARTIN | 8 | 2013–2018 |
| DE AGUIAR PENA PAULA C | 7 | 2013–2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| Los Angeles, California, US | 45 | 2009–2021 |
| Thousand Oaks, California, US | 16 | 2005–2011 |
| Gaithersburg, Maryland, US | 8 | 1994–2003 |
| Westlake Village, California, US | 6 | 1999–2003 |
| Newark, Delaware, US | 6 | 1997–2003 |